Skip to content

HUMAW

Humacyte, Inc.

NASDAQ · Healthcare · Biotechnology · US

$0.00
−78.05%
Ask drillr

Next report

Analyst consensus

Next report date
Nov 6, 2026
EPS estimate
-$0.09
Revenue estimate
$769.4K

Latest reported

Last report date
Aug 12, 2026
EPS actual
-$0.16
EPS estimate
-$0.11
Revenue actual
$406.0K
Revenue estimate
$1.0M

Track record

Trailing twelve quarters

EPS beats (12Q)
3
EPS misses (12Q)
1
EPS in line (12Q)
0
Avg surprise (4Q)
+2.3%
Revenue beats (12Q)
0
Reported history
Report dateEPS estimateEPS actualSurpriseRevenue actual
Aug 12, 2026-$0.11-$0.16Miss -41.04%$406.0K
May 13, 2026-$0.12-$0.09Beat 22.21%$495.0K
Mar 27, 2026-$0.13-$0.13Beat 1.25%$467.0K
Nov 12, 2025-$0.15-$0.11Beat 26.77%$753.0K
Sep 29, 2023-$0.00

Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 11, 2026